Screener
IXJ vs IBB
iShares Global Healthcare ETF vs iShares Biotechnology ETF
Key differences
- Over the last 3 years, IBB has delivered higher annualized returns.
Side-by-side comparison
| IXJ | IBB | |
|---|---|---|
| Annual cost (TER) | 0.40% | 0.44% |
| Fund size (AUM) | $3.6B | $7.9B |
| Since | 2001 | 2001 |
| Dividend yield | 1.46% | 0.23% |
| Asset class | equity | equity |
| Region | — | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +13.6% | +39.0% |
| CAGR 3Y | +5.1% | +9.6% |
| CAGR 5Y | +4.6% | +2.7% |
| Sharpe 3Y | 0.17 | 0.38 |
| Volatility 1Y | 14.45% | 19.75% |
| Max drawdown | -27.35% | -39.82% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to IXJ and IBB
Explore further